<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:38:31Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10524818" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10524818</identifier>
        <datestamp>2023-09-29</datestamp>
        <setSpec>yjbm</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Yale J Biol Med</journal-id>
              <journal-id journal-id-type="iso-abbrev">Yale J Biol Med</journal-id>
              <journal-id journal-id-type="publisher-id">YJBM</journal-id>
              <journal-title-group>
                <journal-title>The Yale Journal of Biology and Medicine</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0044-0086</issn>
              <issn pub-type="epub">1551-4056</issn>
              <publisher>
                <publisher-name>YJBM</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10524818</article-id>
              <article-id pub-id-type="pmcid">PMC10524818</article-id>
              <article-id pub-id-type="pmc-uid">10524818</article-id>
              <article-id pub-id-type="pmid">37781001</article-id>
              <article-id pub-id-type="pmid">37781001</article-id>
              <article-id pub-id-type="doi">10.59249/IAJU7580</article-id>
              <article-id pub-id-type="publisher-id">yjbm963327</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Contribution</subject>
                </subj-group>
                <series-title>Focus: Big Data</series-title>
              </article-categories>
              <title-group>
                <article-title>Comparative Effectiveness Analysis of Lumpectomy and Mastectomy for
Elderly Female Breast Cancer Patients: A Deep Learning-based Big Data
Analysis</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Jiping</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zhang</surname>
                    <given-names>Shunqin</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                  <xref rid="A2" ref-type="aff">b</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yi</surname>
                    <given-names>Huangdi</given-names>
                  </name>
                  <xref rid="A3" ref-type="aff">c</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ma</surname>
                    <given-names>Shuangge</given-names>
                  </name>
                  <xref rid="A1" ref-type="aff">a</xref>
                  <xref rid="COR1" ref-type="corresp">*</xref>
                </contrib>
                <aff id="A1"><label>a</label>Department of Biostatistics, Yale School of Public
Health, New Haven, CT, USA</aff>
                <aff id="A2"><label>b</label>School of Mathematical Sciences, University of Chinese
Academy of Sciences; Key Laboratory of Big Data Mining and Knowledge Management,
Chinese Academy of Sciences, Beijing, China</aff>
                <aff id="A3"><label>c</label>Servier Pharmaceuticals, Boston, MA, USA</aff>
              </contrib-group>
              <author-notes>
                <corresp id="COR1"><label>*</label>To whom all correspondence should be addressed:
Shuangge Ma, Department of Biostatistics, Yale School of Public Health, New
Haven, CT; Email: Shuangge.ma@yale.edu.</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>29</day>
                <month>9</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>9</month>
                <year>2023</year>
              </pub-date>
              <volume>96</volume>
              <issue>3</issue>
              <fpage>327</fpage>
              <lpage>346</lpage>
              <permissions>
                <copyright-statement>Copyright ©2023, Yale Journal of Biology and
Medicine</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder>Yale Journal of Biology and Medicine</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the
Creative Commons CC BY-NC license, which permits use, distribution, and
reproduction in any medium, provided the original work is properly cited.
You may not use the material for commercial purposes.</license-p>
                </license>
              </permissions>
              <abstract>
                <p><bold>Objectives</bold>: To evaluate the comparative effectiveness of treatments,
a randomized clinical trial remains the gold standard but can be challenged by a
high cost, a limited sample size, an inability to fully reflect the real world,
and feasibility concerns. The objective is to showcase a big data approach that
takes advantage of large electronic medical record (EMR) data to emulate
clinical trials. To overcome the limitations of regression analysis, a deep
learning-based analysis pipeline was developed. <bold>Study Design and
Setting</bold>: Lumpectomy (breast-conserving surgery) and mastectomy are
the two most commonly used surgical procedures for early-stage female breast
cancer patients. An emulation trial was designed using the Surveillance,
Epidemiology, and End Results (SEER)-Medicare data to evaluate their relative
effectiveness in overall survival. The analysis pipeline consisted of a
propensity score step, a weighted survival analysis step, and a bootstrap
inference step. <bold>Results</bold>: A total of 65,997 subjects were enrolled
in the emulated trial, with 50,704 and 15,293 in the lumpectomy and mastectomy
arms, respectively. The two surgery procedures had comparable effects in terms
of overall survival (survival year change = 0.08, 95% confidence interval (CI):
-0.08, 0.25) for the elderly SEER-Medicare early-stage female breast cancer
patients. <bold>Conclusion</bold>: This study demonstrated the power of “mining
large EMR data + deep learning-based analysis,” and the proposed analysis
strategy and technique can be potentially broadly applicable. It provided
convincing evidence of the comparative effectiveness of lumpectomy and
mastectomy.</p>
              </abstract>
              <kwd-group>
                <kwd>Electronic medical record</kwd>
                <kwd>Deep learning</kwd>
                <kwd>Emulation</kwd>
                <kwd>Breast cancer</kwd>
                <kwd>Lumpectomy</kwd>
                <kwd>Mastectomy</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p>To evaluate the comparative effectiveness of treatments (drugs, operation procedures,
etc.), a rigorously designed and executed randomized clinical trial (RCT) remains
the criterion standard. However, challenges have been well recognized. With a high
cost, RCTs, although statistically sufficiently powered by design, often have
limited sample sizes. It has been repeatedly observed that treatment effects seen in
the real world may differ (sometimes significantly) from RCTs, which can be
attributed to the higher-than-standard care, higher adherence, and other factors in
RCTs. Additionally, for treatments that have been on the market and widely used,
there are feasibility concerns for conducting new head-to-head comparison trials.
The fast accumulation of data from registries, large electronic medical records
(EMR) and insurance claims databases, such as data contained in the SEER
(Surveillance, Epidemiology, and End Results) registries, Medicare, Medicaid, and
Kaiser, as well as the development of data management techniques, have made it
possible to mine a large amount of real-world data to complement RCTs.
Comparatively, such analysis can be advantageous with a much larger sample size and
hence significantly more power, a better reflection of real-world evidence, high
cost-effectiveness, and limited feasibility hurdles. Among the available
observational data analysis methods (that aim to complement RCT analysis), emulation
has attracted special attention, with its trial-like design, potential for causal
interpretations, and scalability [<xref rid="R1" ref-type="bibr">1</xref>].
Emulation analysis has been conducted on cancers [<xref rid="R2" ref-type="bibr">2</xref>-<xref rid="R4" ref-type="bibr">4</xref>], cardiovascular diseases
[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>], and many other diseases [<xref rid="R7" ref-type="bibr">7</xref>-<xref rid="R11" ref-type="bibr">11</xref>]. The first objective of this study is to
present another showcase of the emulation analysis of large EMR data.</p>
              <p>In RCT
analysis, regression techniques (such as linear, logistic, and Cox regressions as
well as t and logrank tests) remain the common practice. This is also true for
emulation analysis [<xref rid="R1" ref-type="bibr">1</xref>]. As in the real world
there is no randomized assignment, emulation analysis usually demands an additional
propensity score step, which can be accomplished by logistic regression [<xref rid="R12" ref-type="bibr">12</xref>]. Regression analysis is easy to conduct and
has lucid interpretation. On the other hand, it is often challenged by “suboptimal”
estimation and prediction performance and stringent model assumptions (and hence an
inability to accommodate, for example, unknown nonlinear effects) – such limitations
can be overcome by deep learning, which has experienced an unparallel surge in the
past few years. Deep learning has demonstrated great power in diverse fields such as
engineering, business, and social science [<xref rid="R13" ref-type="bibr">13</xref>-<xref rid="R15" ref-type="bibr">15</xref>]. It has been applied in
biomedical research to the analysis of epidemiological [<xref rid="R16" ref-type="bibr">16</xref>], omics [<xref rid="R17" ref-type="bibr">17</xref>], imaging
[<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref>], and other types of data [<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref>]. Our literature review
suggests that the application of deep learning in the emulation analysis of
observational data has been very limited. Additionally, “classic” deep learning
techniques have been criticized as “black boxes.” As such, the second objective of
this study is to develop a deep learning-based emulation analysis pipeline, which
may have broad applications far beyond this study. The proposed deep neural network
(DNN) approaches inherit strengths from well-established statistical principles and
“classic” DNNs and can be superior to both.</p>
              <p>For early-stage breast cancer, the
surgical treatment options include mastectomy (which removes the entire breast) and
lumpectomy (which removes a tumor and some normal tissues surrounding it). In the
past decades, studies have hinted at the equivalency of the two surgical procedures,
and both have been extensively conducted in clinical practice. However, RCTs may
potentially suffer from a lack of generalizability due to extensive exclusion
criteria, and previous evidence and findings from RCTs were based on cohorts from
the 1980s [<xref rid="R22" ref-type="bibr">22</xref>-<xref rid="R25" ref-type="bibr">25</xref>]. Since then, there have been significant developments in breast
cancer detection and treatment, such as a better understanding of tumor biology and
advancements in surgical techniques and adjuvant therapy. With the period effect,
patient characteristics have also changed significantly over time. It is thus of
interest to compare breast cancer outcomes for patients who underwent the two
surgical procedures in a more recent era. Another critical limitation of the
existing RCTs and some observational studies is that there was insufficient
attention to the elderly patients – many of them excluded elderly women or only
included a very limited number of elderly women. The undertreatment and
underrepresentation of elderly patients in studies may be attributable to limited
cosmetic needs, a shorter life expectancy, an increasing incidence of comorbidities,
and other factors. Breast cancer disproportionately affects older women, with those
over 65 having the highest age-specific probability of developing invasive diseases
[<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref>]. The third objective of this study is to evaluate the comparative
effectiveness of mastectomy and lumpectomy for the overall survival of elderly
female breast cancer patients diagnosed and treated more recently. This effort can
complement the existing RCT and observational studies and directly inform breast
cancer clinical practice.</p>
            </sec>
            <sec sec-type="methods" id="s2">
              <title>Methods</title>
              <sec id="s2a">
                <title>Data and Study Sample</title>
                <p>The SEER-Medicare data was analyzed in this study. Surveillance, Epidemiology,
and End Results (SEER) contains 22 cancer registries in the United States.
Medicare is a federally-funded health insurance program in the US, and in 2010,
approximately 94% of the US population age 65 years or older was enrolled in
Medicare. The SEER-Medicare data provides an ideal opportunity to study the US
elderly cancer population. It has been extensively analyzed, including in
emulation analysis [<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R28" ref-type="bibr">28</xref>]. Here, it is noted that the adopted
mining observational data for emulation analysis strategy and deep
learning-based analysis pipeline can be directly applied to other databases.
Data analyzed in this study was obtained through a Data Use Agreement (DUA) by
the National Cancer Institute (NCI). The study design was motivated by relevant
RCTs [<xref rid="R22" ref-type="bibr">22</xref>-<xref rid="R25" ref-type="bibr">25</xref>] and observational analysis [<xref rid="R29" ref-type="bibr">29</xref>-<xref rid="R32" ref-type="bibr">32</xref>], while taking into
consideration data availability in the SEER-Medicare database. The target and
emulated trial designs are described in Appendix Table S1. The flowchart of
emulated trial patient selection is summarized in <xref rid="F1" ref-type="fig">Figure 1</xref>. Briefly, the emulated trial enrolled Medicare
beneficiaries with first primary invasive intraductal or/and lobular breast
cancer (International Classification of Diseases for Oncology, 3rd Edition
(ICD-O-3): 8500, 8520, and 8522) who were: 1) female and 66-100 years old at
diagnosis, 2) diagnosed between 1/1/07 and 12/31/17, 3) stage I-II, 4) with
tumor size ≤ 5cm, 5) received lumpectomy or mastectomy within 120 days after
diagnosis, and 6) had continuous enrollment in Medicare Part A and Part B, with
no health maintenance organization (HMO) enrollment from one year before to one
year after the cancer diagnosis or death, whichever occurred first. A subject
was excluded if she 1) was reported from registries in New York (NY),
Massachusetts (MA), and Idaho (ID) because of missing cancer-related information
(eg, stage), 2) had missing information on month of diagnosis, gender, stage or
tumor size, and 3) was reported from death certificate or autopsy.</p>
              </sec>
              <sec id="s2b">
                <title>Variable Information</title>
                <p>After reviewing the relevant observational studies, and also considering data
availability, we included the following variables as potential confounders,
which may have an impact on treatment initiation (choice of surgery) and outcome
(overall survival): 1) baseline demographics: age, race, and marital status; 2)
cancer-related variables: tumor size, morphology, stage, primary site,
laterality, grade, HR status; and 3) comorbidities: Elixhauser comorbid
conditions index. It is noted that human epidermal growth factor receptor 2
(HER2) was not measured for patients diagnosed prior to 2010, and, as such, it
was not included in the main analysis. In addition, as only a few (&lt;11)
patients had unknown laterality or paired site/midline tumor, they were excluded
from the analysis. A patient was enrolled into the lumpectomy arm if she
received lumpectomy as the first surgery procedure after being diagnosed and
would be censored if a subsequent mastectomy was performed. A patient was
enrolled into the mastectomy arm if she received mastectomy as the first surgery
procedure after being diagnosed regardless of subsequent surgical procedures.
The International Classification of Diseases, Ninth Revision, Clinical
Modification (ICD-9-CM), ICD-10-CM, and the Healthcare Common Procedure Coding
System (HCPCS)/Current Procedural Terminology (CPT) codes appeared in Medicare
inpatient and outpatient records were adopted to define surgeries. Details are
provided in Appendix A: Table S2. Time zero was set as the time of surgery.
Immortal time bias, if any, is expected to be limited, as the two treatment
groups were comparable and the mortality rate right after diagnosis was very low
compared to the long follow-up. The overall survival information was obtained
from the Medicare records. All subjects were followed to the end of 2019 or
death, whichever happened first.</p>
              </sec>
              <sec id="s2c">
                <title>A DNN-based Analysis Pipeline</title>
                <p>Under the regression framework, the emulation technique has been well developed.
We refer to [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R33" ref-type="bibr">33</xref>] for methodological developments and [<xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R34" ref-type="bibr">34</xref>]
for representative case studies. Additionally, some computer codes are also
publicly available, for example at [<xref rid="R35" ref-type="bibr">35</xref>].
Briefly, to emulate the estimation of an intention-to-treat (ITT) effect, the
observed treatments in medical records are used as treatment assignments.
Special considerations may be needed if a patient received multiple treatments.
In a well-executed RCT, different arms can be sufficiently balanced. As such,
there may be no need for accounting for confounding – although it is still
commonly done out of caution. In the emulation analysis of observational data,
since randomization did not really happen, there is a risk of imbalance. To
tackle this problem, the propensity score and inverse probability treatment
(IPT) weighting techniques are usually adopted to achieve baseline balance as in
an RCT. The propensity score calculation is usually built on logistic regression
that includes the treatment indicator as response and baseline covariates as
covariates. Usually, this analysis only includes linear effects. Based on the
logistic regression results, the IPT weight can be calculated as the inverse of
the propensity score for one treatment group and the inverse of one minus the
propensity score for the other group. Stabilized weights with a truncation at
the upper 99.5% percentile (that is, if a weight is above the 99.5% percentile,
it is set as the 99.5% percentile) are usually adopted for retaining the same
group size ratio and avoiding putting extreme weights on certain subjects. With
such weights, a pseudo-population can be created, for which there is no (or very
weak) association between the baseline confounders and received treatment. Then,
survival analysis, for example, Cox regression, can be conducted using the
weighted pseudo-population to estimate the causal effect under the assumption of
no unmeasured confounders. Similar to logistic regression, Cox and other
survival analysis models also rely on strong assumptions and linear effects. In
practice, it is not uncommon to observe violations of such assumptions.</p>
                <p>Our
overall strategy is to follow the above framework but replace regression-based
analysis with DNN-based analysis, which relies on weaker model assumptions and
can “automatically” accommodate unspecified nonlinear relationships. The
architecture of the DNNs for both propensity score and survival analysis steps
is sketched in <xref rid="F2" ref-type="fig">Figure 2</xref> and consists of a
sparse layer, multiple hidden layers, and an output layer. The key building
components of a DNN include its loss function and estimation approach, which are
presented below. Denote <italic>n</italic> as the number of independent
subjects. For subject <italic>i</italic>, we observe <italic>p</italic> baseline
covariates <italic><bold>X</bold><sub>i</sub></italic> =
(<italic><bold>X</bold></italic><sub><italic>i</italic>1</sub>, ... ,
<italic>X<sub>ip</sub></italic>)<sup><italic>T</italic></sup>, a binary
treatment indicator <italic>Z<sub>i</sub></italic>, and right censored survival
outcome {<italic>Y<sub>i</sub></italic> =
min(<italic>T<sub>i</sub></italic><italic>,C<sub>i</sub></italic>),
<italic>δ<sub>i</sub></italic> = I(<italic>T<sub>i</sub></italic> ≤
<italic>C<sub>i</sub></italic>)}. Here,
<italic>T<sub>i</sub></italic><italic>, C<sub>i</sub></italic> are the event
and censoring times, respectively, and I(∙) is the indicator function.</p>
                <p><italic>Propensity score step</italic>. A feed-forward DNN is constructed with
input being <italic><bold>X</bold><sub>i</sub></italic>’s after standardization
for continuous variables and one-hot encoding for categorical variables and
output being <italic>Z<sub>i</sub></italic>,’s. EMR databases contain rich
information, and collecting data from such databases is almost free. As such, to
avoid losing important information, “more than necessary” covariates may be
included. In addition, in regression-based emulation analysis, it is also
commonly observed that some covariates are not significant. For the proposed
DNN, we first propose imposing group Lasso penalization to the input layer
weights. In particular, the weights corresponding to one input variable are
treated as a group. Group Lasso has been extensively developed under the
regression framework and has the “group in or group out” selection property
[<xref rid="R36" ref-type="bibr">36</xref>]. With this penalty, we are able
to distinguish important input variables from noises, which can lead to a
simpler DNN structure, fewer variables and hence more stable estimation, and
more lucid interpretations. Additionally, we also propose applying ridge
penalization [<xref rid="R37" ref-type="bibr">37</xref>] to the hidden layer
weights. Here, the goal is to regularize estimation and avoid extreme values. In
principle, it is possible to also apply group Lasso (or its individual
counterpart Lasso). However, this may lead to an overly sparse DNN and unstable
optimization.</p>
                <p>Use <italic><bold>α</bold></italic><sub>1</sub>,<sub><italic>j</italic></sub>, a
vector, where <italic>j</italic> = 1, ... ,<italic>p</italic>, to denote the
input layer weights corresponding to the <italic>j</italic>th input variable,
and <bold>A</bold><sub><italic>k</italic>1</sub>, a matrix, where
<italic>k</italic><sub>1</sub> = 1, ... ,<italic>K</italic><sub>1</sub>, to
denote the weights of the <italic>k</italic><sub>1</sub>th hidden layer.
Additionally, use A to collectively denote all weights. For subject
<italic>j</italic> denote <mml:math id="M1" overflow="scroll"><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Α</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">X</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math> as the probability output (that is, a Sigmoid activation function is
adopted for the output layer). Intuitively,
<italic>h</italic><sub>A</sub>(<italic><bold>X</bold><sub>i</sub></italic>)
corresponds to the covariate effect in logistic regression. For the input layer
and hidden layers, respectively, we adopt the Tanh and Hardtanh activation
functions. We adopt the logarithmic loss function (binary cross-entropy), which
has connections with the logistic likelihood function, and has been popularly
adopted. This has been partly motivated by the fact that, in the literature,
logistic regression has been popularly adopted in propensity score estimation
and has demonstrated sensible performance. The overall penalized loss function
is:</p>
                <p>
                  <mml:math id="M2" overflow="scroll">
                    <mml:mstyle mathsize="8pt">
                      <mml:msub>
                        <mml:mrow>
                          <mml:mi>l</mml:mi>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:mn>1</mml:mn>
                        </mml:mrow>
                      </mml:msub>
                      <mml:mo>=</mml:mo>
                      <mml:mo>-</mml:mo>
                      <mml:mfrac>
                        <mml:mrow>
                          <mml:mn>1</mml:mn>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:mi>n</mml:mi>
                        </mml:mrow>
                      </mml:mfrac>
                      <mml:mrow>
                        <mml:msubsup>
                          <mml:mo stretchy="false">∑</mml:mo>
                          <mml:mrow>
                            <mml:mi>i</mml:mi>
                            <mml:mo>=</mml:mo>
                            <mml:mn>1</mml:mn>
                          </mml:mrow>
                          <mml:mrow>
                            <mml:mi>n</mml:mi>
                          </mml:mrow>
                        </mml:msubsup>
                        <mml:mrow>
                          <mml:mfenced separators="|">
                            <mml:mrow>
                              <mml:msub>
                                <mml:mrow>
                                  <mml:mi>Z</mml:mi>
                                </mml:mrow>
                                <mml:mrow>
                                  <mml:mi>i</mml:mi>
                                </mml:mrow>
                              </mml:msub>
                              <mml:mo>×</mml:mo>
                              <mml:msub>
                                <mml:mrow>
                                  <mml:mi>h</mml:mi>
                                </mml:mrow>
                                <mml:mrow>
                                  <mml:mi mathvariant="normal">Α</mml:mi>
                                </mml:mrow>
                              </mml:msub>
                              <mml:mfenced separators="|">
                                <mml:mrow>
                                  <mml:msub>
                                    <mml:mrow>
                                      <mml:mi mathvariant="bold-italic">X</mml:mi>
                                    </mml:mrow>
                                    <mml:mrow>
                                      <mml:mi>i</mml:mi>
                                    </mml:mrow>
                                  </mml:msub>
                                </mml:mrow>
                              </mml:mfenced>
                              <mml:mo>-</mml:mo>
                              <mml:mrow>
                                <mml:mrow>
                                  <mml:mi mathvariant="normal">log</mml:mi>
                                </mml:mrow>
                                <mml:mo>⁡</mml:mo>
                                <mml:mrow>
                                  <mml:mfenced separators="|">
                                    <mml:mrow>
                                      <mml:mn>1</mml:mn>
                                      <mml:mo>+</mml:mo>
                                      <mml:mrow>
                                        <mml:mrow>
                                          <mml:mi mathvariant="normal">exp</mml:mi>
                                        </mml:mrow>
                                        <mml:mo>⁡</mml:mo>
                                        <mml:mrow>
                                          <mml:mfenced separators="|">
                                            <mml:mrow>
                                              <mml:msub>
                                                <mml:mrow>
                                                  <mml:mi>h</mml:mi>
                                                </mml:mrow>
                                                <mml:mrow>
                                                  <mml:mi mathvariant="normal">Α</mml:mi>
                                                </mml:mrow>
                                              </mml:msub>
                                              <mml:mfenced separators="|">
                                                <mml:mrow>
                                                  <mml:msub>
                                                    <mml:mrow>
                                                      <mml:mi mathvariant="bold-italic">X</mml:mi>
                                                    </mml:mrow>
                                                    <mml:mrow>
                                                      <mml:mi>i</mml:mi>
                                                    </mml:mrow>
                                                  </mml:msub>
                                                </mml:mrow>
                                              </mml:mfenced>
                                            </mml:mrow>
                                          </mml:mfenced>
                                        </mml:mrow>
                                      </mml:mrow>
                                    </mml:mrow>
                                  </mml:mfenced>
                                </mml:mrow>
                              </mml:mrow>
                            </mml:mrow>
                          </mml:mfenced>
                        </mml:mrow>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                      <mml:msub>
                        <mml:mrow>
                          <mml:mi>λ</mml:mi>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:mn>1</mml:mn>
                        </mml:mrow>
                      </mml:msub>
                      <mml:mrow>
                        <mml:msubsup>
                          <mml:mo stretchy="false">∑</mml:mo>
                          <mml:mrow>
                            <mml:mi>j</mml:mi>
                            <mml:mo>=</mml:mo>
                            <mml:mn>1</mml:mn>
                          </mml:mrow>
                          <mml:mrow>
                            <mml:mi>p</mml:mi>
                          </mml:mrow>
                        </mml:msubsup>
                        <mml:mrow>
                          <mml:msub>
                            <mml:mrow>
                              <mml:mfenced open="‖" close="‖" separators="|">
                                <mml:mrow>
                                  <mml:msub>
                                    <mml:mrow>
                                      <mml:mi mathvariant="bold-italic">α</mml:mi>
                                    </mml:mrow>
                                    <mml:mrow>
                                      <mml:mn>1</mml:mn>
                                      <mml:mo>,</mml:mo>
                                      <mml:mi>j</mml:mi>
                                    </mml:mrow>
                                  </mml:msub>
                                </mml:mrow>
                              </mml:mfenced>
                            </mml:mrow>
                            <mml:mrow>
                              <mml:mn>2</mml:mn>
                            </mml:mrow>
                          </mml:msub>
                        </mml:mrow>
                      </mml:mrow>
                      <mml:mo>+</mml:mo>
                      <mml:msub>
                        <mml:mrow>
                          <mml:mi>λ</mml:mi>
                        </mml:mrow>
                        <mml:mrow>
                          <mml:mn>2</mml:mn>
                        </mml:mrow>
                      </mml:msub>
                      <mml:mrow>
                        <mml:msubsup>
                          <mml:mo stretchy="false">∑</mml:mo>
                          <mml:mrow>
                            <mml:msub>
                              <mml:mrow>
                                <mml:mi>k</mml:mi>
                              </mml:mrow>
                              <mml:mrow>
                                <mml:mn>1</mml:mn>
                              </mml:mrow>
                            </mml:msub>
                            <mml:mo>=</mml:mo>
                            <mml:mn>1</mml:mn>
                          </mml:mrow>
                          <mml:mrow>
                            <mml:msub>
                              <mml:mrow>
                                <mml:mi>K</mml:mi>
                              </mml:mrow>
                              <mml:mrow>
                                <mml:mn>1</mml:mn>
                              </mml:mrow>
                            </mml:msub>
                          </mml:mrow>
                        </mml:msubsup>
                        <mml:mrow>
                          <mml:msubsup>
                            <mml:mrow>
                              <mml:mfenced open="‖" close="‖" separators="|">
                                <mml:mrow>
                                  <mml:msub>
                                    <mml:mrow>
                                      <mml:mi mathvariant="bold">Α</mml:mi>
                                    </mml:mrow>
                                    <mml:mrow>
                                      <mml:mi>k</mml:mi>
                                    </mml:mrow>
                                  </mml:msub>
                                </mml:mrow>
                              </mml:mfenced>
                            </mml:mrow>
                            <mml:mrow>
                              <mml:mi>F</mml:mi>
                            </mml:mrow>
                            <mml:mrow>
                              <mml:mn>2</mml:mn>
                            </mml:mrow>
                          </mml:msubsup>
                        </mml:mrow>
                      </mml:mrow>
                    </mml:mstyle>
                  </mml:math>
                </p>
                <p>where <italic>λ</italic><sub>1 </sub>and <italic>λ</italic><sub>2 </sub>are
tuning parameters, ║∙║<sub>2</sub> denotes the
<italic>l</italic><sub>2</sub>-norm, and ║∙║<sub>F</sub> denotes the Frobenius
norm. Denote the estimate of A as Â and <mml:math id="M3" overflow="scroll"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi mathvariant="normal">exp</mml:mi></mml:mrow><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mo>-</mml:mo><mml:mi>h</mml:mi></mml:mrow><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">Α</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">X</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mfrac></mml:math>. Following regression-based analysis, we calculate the inverse
probability treatment weight: if subject <italic>i</italic> is in the treatment
arm, <mml:math id="M4" overflow="scroll"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math>; otherwise, <mml:math id="M5" overflow="scroll"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math>.</p>
                <p><italic>Survival analysis step</italic>. In regression analysis, the Cox model
has been widely used because of clear interpretation and easy implementation,
although alternative models have also been extensively adopted. In deep
learning, a loss function that corresponds to the negative partial likelihood
function of the Cox model has been developed [<xref rid="R38" ref-type="bibr">38</xref>]. However, it is not as popular as its counterpart under
regression. Here, we develop an alternative loss function.</p>
                <p>For subject <italic>i</italic> = 1, ... ,<italic>n</italic>, consider weight <mml:math id="M6" overflow="scroll"><mml:msub><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfrac></mml:math> where <italic>S</italic>(<italic>t</italic>) is the survival
function for the event time of interest. In practice, we estimate
<italic>S</italic>(<italic>t</italic>) using the Kaplan-Meier estimator
<italic>Ŝ</italic>(<italic>t</italic>) and denote the corresponding weight
as <mml:math id="M7" overflow="scroll"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math>. We construct a feed-forward weighted DNN with
(<italic>Z<sub>i</sub></italic>,<italic><bold>X</bold><sub>i</sub></italic>)’s
as input and <italic>Y<sub>i</sub></italic>’s as output. For subject
<italic>i</italic>, <mml:math id="M8" overflow="scroll"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math> is imposed as weight. Note that the weight calculation does not
depend on the DNN construction. In addition, censored subjects have zero
weights, and as such, are virtually removed from the DNN analysis. For the input
layer, the Tanh activation function is adopted. For the hidden and output
layers, the Rectified Linear Units (ReLU) activation function is adopted. For
the <italic>j</italic>th input variable, use
<italic><bold>β</bold></italic><sub>1</sub>,<sub><italic>j</italic></sub>, a
vector, to denote its input layer weights. For the
<italic>k</italic><sub>2</sub>th (= 1, ... ,<italic>K</italic><sub>2</sub>)
hidden layer, use <bold>B</bold><sub><italic>k</italic>2</sub>, a matrix, to
denote its collection of weights. And use B to collectively denote all network
weights. For subject <italic>i</italic> denote
<italic>f</italic><sub>B</sub>(<italic>Z<sub>i</sub></italic>,
<italic><bold>X</bold><sub>i</sub></italic>) the network output.
Following the same penalization strategy as above, we propose the loss function: <mml:math id="M9" overflow="scroll"><mml:mstyle mathsize="8pt"><mml:msub><mml:mrow><mml:mi>l</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow/></mml:msubsup><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mfenced open="{" close="}" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mfenced open="{" close="}" separators="|"><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow><mml:mrow/></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Β</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">X</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>p</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mfenced open="‖" close="‖" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">β</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mn>4</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msubsup><mml:mrow><mml:msubsup><mml:mrow><mml:mfenced open="‖" close="‖" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">Β</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mstyle></mml:math>, where <italic>λ</italic><sub>3</sub> and
<italic>λ</italic><sub>4</sub> are tuning parameters. The first term has a
least squares form, which makes computation simple.</p>
                <p>The proposed loss has been motivated by the accelerated failure time (AFT) model
[<xref rid="R39" ref-type="bibr">39</xref>]. Compared to the Cox model, the
AFT model can sometimes be preferred because of its more lucid interpretation
and simpler computation. Although it has been widely adopted in regression, its
DNN development has not been well pursued. This study can fill this important
knowledge gap. There can be multiple estimation approaches under the AFT
modeling. We adopt the weighted least squares technique [<xref rid="R40" ref-type="bibr">40</xref>,<xref rid="R41" ref-type="bibr">41</xref>], which has
the lowest computational cost and can be easily combined with the IPT
weighting.</p>
                <p><italic>Inference on treatment effect.</italic> In RCT analysis, quantification
of the significance of the treatment effect (using p-value, confidence interval,
etc.) can be as important as estimation. In most of the existing DNN studies,
there has been a lack of attention to the effect of an individual input variable
and the quantification of its significance. To fill this knowledge gap, for the
proposed analysis, we propose estimating treatment effects through a permutation
of the treatment indicator <italic>Z<sub>i</sub></italic> for each subject. That
is, the population treatment effect is defined as the average increase/decrease
in predicted survival time if switching <italic>Z<sub>i</sub></italic> = 1 to
<italic>Z<sub>i</sub></italic> = 0 (and vice versa) for the whole
cohort. For inference, we propose a weighted bootstrap technique, which has been
motivated by the weighted bootstrap for regression analysis [<xref rid="R42" ref-type="bibr">42</xref>] and consists of the following
steps:</p>
                <p>1) Randomly generate <italic>η</italic><sub>1</sub>, ... ,
<italic>η</italic><sub>η</sub> from exp(1), the exponential distribution
with rate = 1.</p>
                <p>2) Conduct the weighted penalized estimation. In particular, the first term in
the survival analysis objective function is revised as <mml:math id="M10" overflow="scroll"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow/></mml:msubsup><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mfenced open="{" close="}" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced><mml:msub><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mfenced open="{" close="}" separators="|"><mml:mrow><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:msub><mml:mrow><mml:mi>δ</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow><mml:mrow/></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>η</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>μ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>π</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Y</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Β</mml:mi></mml:mrow></mml:msub><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>Z</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold-italic">X</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math>. The penalty terms remain unchanged.</p>
                <p>3) Repeat Steps 1) - 2), eg, 500 times. The resulted estimates are used to
construct a confidence interval (CI) for the treatment effect.</p>
                <p><italic>Computation.</italic> The bootstrap analysis can be conducted using the
same approach as without the exponential weights. For both the propensity score
and survival analysis steps, we adopt state-of-the-art techniques, including
input standardization, Adaptive Moment Estimation for the gradient descent
algorithm, Nesterov momentum, and learning rate scheduling with the exponential
decay technique. We perform a Random hyperparameter optimization search and tune
network depth and size, learning rate, penalization parameters, dropout rate,
exponential learning rate decay constant, and momentum, with the assistance of
the Python package Optunity. For tuning parameter selection, we conduct a grid
search and minimize the cross entropy in the propensity score step and the
weighted mean squared error in the survival analysis step. As the sample size is
much larger than the number of parameters, cross-validation is not adopted but
can be easily revised. The open-source Python module PyTorch is adopted.</p>
                <p><italic>Sensitivity analysis</italic>. In the main analysis, HER2 was not
included because of complete missingness for patients diagnosed prior to 2010.
It is recognized that HER2 is an important confounder and may impact both
surgical choices and overall survival. In Appendix A: S1, analysis was conducted
on a revised cohort with available HER2 information (that is, patients diagnosed
in or after 2010), and HER2 was included as a confounder. Additionally, it was
recognized that whether to perform radiotherapy was still being debated. Also
motivated by the observed high proportion of patients receiving adjuvant
radiotherapy after lumpectomy, we conducted the second sensitivity analysis in
Appendix A: S2 and compared the overall survival of patients receiving
mastectomy without adjuvant radiation therapy versus lumpectomy with radiation
therapy. The ICD-9-CM, ICD-10-CM, HCPCS/CPT codes for identifying radiation
therapy are provided in Appendix Table S2. We further fit a standard Cox
regression model that included all the confounders and compared the results with
those using the deep learning approach.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s3">
              <title>Results</title>
              <p>As shown in <xref rid="F1" ref-type="fig">Figure 1</xref>, a total of 65,997 patients
were enrolled in the emulated trial, with 50,704 in the lumpectomy arm and 15,293 in
the mastectomy arm. The waiting time from diagnosis to surgery was observed to be
short – over 95% of the surgeries were performed within 120 days after diagnosis.
The baseline characteristics are summarized in <xref rid="T1" ref-type="table">Table
1</xref>. It was observed that before the IPT weighting, the patients treated
with lumpectomy were slightly younger, more likely to be stage I and with smaller
tumor size and had lower comorbidity scores.</p>
              <p>The unadjusted Kaplan-Meier survival
curves by treatment are shown in <xref rid="F3" ref-type="fig">Figure 3</xref>. For
the lumpectomy arm, the overall mortality rate and median survival were 22.6% and
6.0 years, respectively. For the mastectomy arm, they were 35.5% and 5.8 years,
respectively. The patients who received lumpectomy were observed to have longer
overall survival (p-value &lt; 0.001 by logrank test). The proportional hazards
assumption was tested, and the global Chi-squared test returned a p-value &lt;
0.001, which justifies the adoption of a more flexible modeling technique.</p>
              <p>In the
propensity score analysis, we evaluated the impact of tuning parameters by
visualizing parameter paths, which is a common technique for penalized estimation
[<xref rid="R43" ref-type="bibr">43</xref>]. The parameter paths as a function
of tuning parameter <italic>λ</italic><sub>1</sub> are shown in <xref rid="F4" ref-type="fig">Figure 4</xref>a. It was observed that tumor size was the only
variable that was included when <italic>λ</italic><sub>1</sub> was large, suggesting
its higher importance. As the penalty level decreases, all variables can be included
into the propensity score model. For example, race and HR status positive also have
relatively larger group norms, which suggests that those variables are important
factors and may be associated with the decision-making between lumpectomy and
mastectomy. <xref rid="F5" ref-type="fig">Figure 5</xref>a and b show the
distributions of the estimated propensity scores and weights. The two treatment
groups have visibly different propensities towards surgical options. As shown in
<xref rid="F5" ref-type="fig">Figure 5</xref>c, prior to the weighting, some of
the absolute standardized mean difference (SMD) values were above the 0.1 threshold,
especially for tumor size and stage. Both variables are important factors to be
considered when making a choice between lumpectomy and mastectomy. All the absolute
SMDs significantly reduced to be below 0.1 and even nearly 0 with the weighting,
with which the two arms could be considered as balanced. For comparison, we also
considered the standard logistic regression approach. The Chi-squared test for
deviance returned a p-value &lt; 0.001, which suggested unsatisfactory model fitting
and hence justified the adoption of DNN.</p>
              <p>In the survival analysis step, we also
examined the parameter paths to assess the relative importance of input variables.
As shown in <xref rid="F4" ref-type="fig">Figure 4</xref>b, overall survival was
found to be highly related to Elixhauser comorbidities and age, which remained in
the model even with larger tuning parameter values (and hence higher penalty).
Subsequently, tumor size and tumor grade III or IV were found to contribute to
survival. Based on the obtained DNN, the predicted subject-level survival would, on
average, slightly increase, if a patient would have switched from lumpectomy to
mastectomy. The result is summarized in <xref rid="F6" ref-type="fig">Figure
6</xref>a. With the predicted survival time for each patient (without
censoring), the Kaplan-Meier survival curves were constructed and shown in <xref rid="F6" ref-type="fig">Figure 6</xref>b and c. In <xref rid="F6" ref-type="fig">Figure 6</xref>b, the treatment assignment was created to be random. The
survival curves of the predicted survival times for the two arms almost completely
overlap (p-value = 0.2 by logrank test). In this assessment, the two surgical groups
are balanced for treatment assignments, mimicking the randomization process in a
well-executed RCT. In comparison, in <xref rid="F6" ref-type="fig">Figure 6</xref>c,
a beneficial effect of lumpectomy (p-value &lt; 0.001 by logrank test) was observed,
if the treatment assignment was based on what was observed and without addressing
potential confounding. This assessment mimics real-world observations where there
are always some inherent differences between those receiving different surgical
procedures. This may also explain why some observational studies concluded that
lumpectomy was associated with improved survival [<xref rid="R29" ref-type="bibr">29</xref>-<xref rid="R32" ref-type="bibr">32</xref>]. Overall, we concluded
that lumpectomy and mastectomy had similar effects on overall survival. For all
subjects in the studied cohort, the average estimated increase in overall survival
is 0.05 years if a patient received lumpectomy in comparison to mastectomy. With the
weighted bootstrap inference, the average mean survival year change (across
bootstraps) was found to be 0.08, with a standard deviation of 0.08 and 95% CI [-0.08,0.25].</p>
              <p>In the sensitivity analysis with respect to HER2, a
similar conclusion was made. In particular, the average estimated increase in
overall survival is 0.094 years if a received lumpectomy in comparison to
mastectomy. With the weighted bootstrap inference, the average mean survival year
change was found to be 0.14, with a standard deviation of 0.08 and 95% CI [-0.02,0.29]. In the sensitivity analysis with respect to radiotherapy, it was
concluded that lumpectomy with radiotherapy was superior. The average estimated
increase in overall survival is 0.30 years if a patient received lumpectomy in
comparison to mastectomy. With the weighted bootstrap inference, the average mean
survival year change was found to be 0.29, with a standard deviation of 0.09 and 95%
CI [0.13,0.49]. It is noted that the definition of time zero changed and that
the results could be subject to immortal time bias (which may result in a misleading
conclusion on the beneficial treatment effect of lumpectomy with radiation therapy).
As such, this conclusion should be taken with caution. With the standard Cox
regression analysis, it was found that lumpectomy was slightly superior, and the
hazard ratio was 0.96, with 95% CI [0.92,0.99]. As the Cox model
failed model diagnostics, the conflict with the deep learning-based analysis is not
surprising. Additionally, it is noted that the estimated treatment under the Cox
model is in fact very small.</p>
            </sec>
            <sec sec-type="discussion" id="s4">
              <title>Discussion</title>
              <p>This article has provided another showcase of mining large observational data,
extracting valuable information, complementing RCTs, and informing clinical
practice. In our data analysis, the sample size is dramatically larger than regular
RCTs, making the analysis much more powerful. It is usually not easy to
significantly increase sample sizes in RCTs. However, with the accumulation of data,
the sample size of this study and other observational data analyses can easily keep
increasing. The analyzed real-world data can be closer to real clinical practice
than RCTs. With a much broader coverage and more diverse population, the findings
can be more generalizable than RCTs. As acknowledged in the literature [<xref rid="R34" ref-type="bibr">34</xref>,<xref rid="R44" ref-type="bibr">44</xref>],
emulation and other big data analysis of observational data can be the most useful
for assessing the effectiveness of existing treatments (that have not been directly
compared in RCTs) and updating comparisons (that have been done years ago on
patients with different characteristics). It is noted that the proposed analysis can
also be done with local data, for example, generated by the Yale New Haven
Healthcare System, to better reflect local clinical practice and patient
characteristics. With the promising performance of deep learning on other biomedical
problems (for example, imaging and omics data analysis), it is a natural step to
develop deep learning-based emulation analysis. The proposed analysis pipeline has
combined the strengths of both statistical analysis and “regular” DNNs.
Specifically, key building blocks of the “standard” DNN architecture have been
retained. As such, the proposed analysis, similar to other DNNs, can have better
estimation/prediction performance and more flexibly accommodate unspecified
nonlinear relationships. It can be especially useful when the logistic, Cox, and
other model assumptions are not satisfied, as in this data analysis. Here, it is
noted that some recent studies have pointed out that DNNs may not be entirely
model-free [<xref rid="R45" ref-type="bibr">45</xref>,<xref rid="R46" ref-type="bibr">46</xref>]. Our literature review suggested that there is still a lack
of model diagnostics tools for DNNs – it will be of interest to diagnose the
proposed DNNs when such tools become available. On the other hand, the proposed
analysis has inherited the lucid framework of emulation analysis, with the clear
propensity score and survival analysis steps. Additionally, it has incorporated
penalized estimation, examination of parameter paths, and bootstrap-based inference,
which are routine in regression analysis but still have not been well developed in
deep learning. It is noted that deep learning is not “free.” Different from
regression analysis, there is a lack of simple models. The resulting DNNs are
available from the authors, however, do not have easily interpretable forms.
Additionally, they do not deliver simple statistics such as hazard ratio. The
proposed assessment based on the predicted survival time can largely alleviate this
problem.</p>
              <p>In data analysis, our main finding is that lumpectomy and mastectomy have
comparable long-term overall survival for early-stage elderly female breast cancer
patients. It is noted that the studied population differs from many of the existing
studies. The conclusion is consistent with most of the existing RCTs and can
complement the existing literature. For example, the National Surgical Adjuvant
Breast and Bowel Project (NSABP) B-04 study [<xref rid="R25" ref-type="bibr">25</xref>] and the study at the National Cancer Institute in Milan [<xref rid="R47" ref-type="bibr">47</xref>] both suggested no difference in 20-year
overall survival after the two surgical procedures. More recent observational
studies, interestingly, reached different conclusions. For example, Agarwal et al.
[<xref rid="R29" ref-type="bibr">29</xref>], Hwang et al. [<xref rid="R30" ref-type="bibr">30</xref>], and Wrubel et al. [<xref rid="R32" ref-type="bibr">32</xref>] concluded that lumpectomy was superior in terms of breast
cancer-specific and overall survival compared to mastectomy. The difference in
findings can be at least partly attributed to the differences in study populations
(for example, different age groups and years of diagnosis). Mogal et al. [<xref rid="R31" ref-type="bibr">31</xref>] specially analyzed elderly patients and
also concluded that lumpectomy was significantly superior in terms of overall
survival. It is noted that all of the above studies adopted regression-based
association analysis techniques. Most of them did not report any model diagnostics,
and there could be a risk of model misspecification. Additionally, some adopted the
Kaplan-Meier technique without addressing possible confounding bias.</p>
              <p>Limitations of
the proposed analysis are fully recognized. SEER-Medicare and other EMR and
insurance claims databases may not have comprehensive and accurate information as
RCTs. For example, to capture most of the observed treatments of interest, we had an
additional inclusion criterion in our emulated trial (compared to the target trial)
as having at least one year or until death enrollment in Medicare part A or B. This
may limit the sample size and introduce a selection bias to our analysis. For the
main data analysis, unmeasured and possibly relevant confounders may include HER2
status, lymphovascular invasion, extracapsular invasion, and size of nodal
metastases, which may have an impact on both surgical choices and prognosis. This is
the practice paid for collecting data for a large population without specific
targets as in RCTs. To partially address this limitation, we conducted a sensitivity
analysis with respect to HER2 status. The proposed analysis may suffer the same
limitations as the existing emulation techniques. For example, it demands a proper
definition of treatment assignment and time zero. Otherwise, it may lead to falsely
defined treatment effects and succumb to immortal time bias. In the main analysis,
we omitted the subsequent chemotherapy, radiotherapy, or endocrine therapy before
and after surgery, as our main interest was in the two surgical procedures. As
discussed in [<xref rid="R29" ref-type="bibr">29</xref>], the indication for
systemic chemotherapy is comparable for both surgical groups, thereby minimizing a
disproportionate impact of chemotherapy. To partially mitigate this limitation, we
additionally conducted a sensitivity analysis with respect to adjuvant radiation
therapy performed after surgery. However, including neoadjuvant and adjuvant
therapies in the analysis may pose a challenge to the proper definition of treatment
and choice of time zero. Future research will be needed to address the corresponding
immortal time bias – otherwise, we may not be able to perform a valid emulation
analysis (but more of an observation analysis informing association). In the
analysis, data from a time window much wider than regular RCTs was pooled. The
analysis can be repeated for shorter time windows to examine potential temporal
variations. It is also recognized that adopting DNN (and other complex modelings)
may have the risk of overfitting. In this study, this risk can be largely mitigated
via penalization, the relatively simple structure of the DNNs, and the large sample
size.</p>
            </sec>
            <sec sec-type="conclusions" id="s5">
              <title>Conclusion</title>
              <p>This study has further advanced big data analysis for biomedicine by developing a
deep learning-based emulation analysis pipeline for mining large observational data
and complementing RCTs. Equally importantly, the analysis of SEER-Medicare data has
led to the conclusion that lumpectomy and mastectomy have similar effects on overall
survival for elderly SEER-Medicare early-stage female breast cancer patients. This
finding can directly inform breast cancer clinical practice.</p>
            </sec>
          </body>
          <back>
            <ack>
              <p>The collection of the California cancer incidence data used in this study was
supported by the California Department of Public Health as part of the statewide
cancer reporting program mandated by California Health and Safety Code Section
103885; the National Cancer Institute’s Surveillance, Epidemiology and End Results
Program under contract N01-PC-35136 awarded to the Northern California Cancer
Center, contract N01-PC-35139 awarded to the University of Southern California, and
contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for
Disease Control and Prevention’s National Program of Cancer Registries, under
agreement #U55/CCR921930-02 awarded to the Public Health Institute. The ideas and
opinions expressed herein are those of the author(s) and endorsement by the State of
California, Department of Public Health the National Cancer Institute, and the
Centers for Disease Control and Prevention or their Contractors and Subcontractors
is not intended nor should be inferred. The authors acknowledge the efforts of the
Applied Research Program, NCI; the Office of Research, Development and Information,
CMS; Information Management Services (IMS), Inc.; and the Surveillance,
Epidemiology, and End Results (SEER) Program tumor registries in the creation of the
SEER-Medicare database. The interpretation and reporting of the SEER-Medicare data
are the sole responsibility of the authors.</p>
            </ack>
            <notes>
              <title>Funding</title>
              <p>This study was partly supported by NIH HL161691 and CA276790.</p>
            </notes>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization: JW, YH, and SM; methodology: JW, SZ, and SM; software: SZ and JW;
validation: JW and SM; formal analysis: JW; investigation: JW, YH, and SM; data
curation: JW; writing—original draft preparation, all; writing—review and editing,
all; supervision: SM. All authors have read and agreed to the published version of
the manuscript.</p>
            </notes>
            <app-group>
              <app>
                <label>Appendix A</label>
                <media xlink:href="yjbm_96_3_327_appendix.pdf" id="d64e1465" position="anchor"/>
              </app>
            </app-group>
            <glossary>
              <def-list>
                <def-item>
                  <term>EMR</term>
                  <def>
                    <p>electronic medical record</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SEER</term>
                  <def>
                    <p>Surveillance, Epidemiology, and End Results</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RCT</term>
                  <def>
                    <p>randomized clinical trial</p>
                  </def>
                </def-item>
                <def-item>
                  <term>DNN</term>
                  <def>
                    <p>deep neural network</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ICD-O-3</term>
                  <def>
                    <p>International Classification of Diseases for Oncology, 3rd Edition</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ICD-9/10-CM</term>
                  <def>
                    <p>International Classification of Diseases, Ninth/Tenth Revision, Clinical
Modification</p>
                  </def>
                </def-item>
                <def-item>
                  <term>HCPCS</term>
                  <def>
                    <p>Healthcare Common procedure Coding System</p>
                  </def>
                </def-item>
                <def-item>
                  <term>CPT</term>
                  <def>
                    <p>Current Procedural Terminology</p>
                  </def>
                </def-item>
                <def-item>
                  <term>IPT</term>
                  <def>
                    <p>inverse probability treatment</p>
                  </def>
                </def-item>
                <def-item>
                  <term>AFT</term>
                  <def>
                    <p>accelerated failure time</p>
                  </def>
                </def-item>
                <def-item>
                  <term>ReLU</term>
                  <def>
                    <p>Rectified Linear Units</p>
                  </def>
                </def-item>
                <def-item>
                  <term>UOQ</term>
                  <def>
                    <p>upper outer quadrant</p>
                  </def>
                </def-item>
                <def-item>
                  <term>UIQ</term>
                  <def>
                    <p>upper inner quadrant</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LOQ</term>
                  <def>
                    <p>lower outer quadrant</p>
                  </def>
                </def-item>
                <def-item>
                  <term>LIQ</term>
                  <def>
                    <p>lower inner quadrant</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SMD</term>
                  <def>
                    <p>standardized mean difference</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <ref-list>
              <ref id="R1">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hernán</surname><given-names>MA</given-names></string-name><string-name><surname>Robins</surname><given-names>JM</given-names></string-name></person-group>. <article-title>Using Big Data to Emulate a Target Trial When a
Randomized Trial Is Not Available</article-title>. <source>Am J
Epidemiol</source>. <year>2016</year><month>Apr</month>;<volume>183</volume>(<issue>8</issue>):<fpage>758</fpage>–<lpage>64</lpage>.
<pub-id pub-id-type="doi">10.1093/aje/kwv254</pub-id><issn>1476-6256</issn><?supplied-pmid 26994063?><pub-id pub-id-type="pmid">26994063</pub-id></mixed-citation>
              </ref>
              <ref id="R2">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maringe</surname><given-names>C</given-names></string-name><string-name><surname>Benitez Majano</surname><given-names>S</given-names></string-name><string-name><surname>Exarchakou</surname><given-names>A</given-names></string-name><string-name><surname>Smith</surname><given-names>M</given-names></string-name><string-name><surname>Rachet</surname><given-names>B</given-names></string-name><string-name><surname>Belot</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group><article-title>Reflection on modern methods: trial emulation in the presence of
immortal-time bias. Assessing the benefit of major surgery for elderly lung
cancer patients using observational data</article-title>. <source>Int J
Epidemiol</source>. <year>2020</year><month>Oct</month>;<volume>49</volume>(<issue>5</issue>):<fpage>1719</fpage>–<lpage>29</lpage>.
<pub-id pub-id-type="doi">10.1093/ije/dyaa057</pub-id><issn>1464-3685</issn><?supplied-pmid 32386426?><pub-id pub-id-type="pmid">32386426</pub-id></mixed-citation>
              </ref>
              <ref id="R3">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petito</surname><given-names>LC</given-names></string-name><string-name><surname>García-Albéniz</surname><given-names>X</given-names></string-name><string-name><surname>Logan</surname><given-names>RW</given-names></string-name><string-name><surname>Howlader</surname><given-names>N</given-names></string-name><string-name><surname>Mariotto</surname><given-names>AB</given-names></string-name><string-name><surname>Dahabreh</surname><given-names>IJ</given-names></string-name><etal>et al.</etal></person-group><article-title>Estimates of Overall Survival in Patients With Cancer Receiving
Different Treatment Regimens: Emulating Hypothetical Target Trials in the
Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked
Database</article-title>. <source>JAMA Netw Open</source>. <year>2020</year><month>Mar</month>;<volume>3</volume>(<issue>3</issue>):<fpage>e200452</fpage>.
<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.0452</pub-id><issn>2574-3805</issn><?supplied-pmid 32134464?><pub-id pub-id-type="pmid">32134464</pub-id></mixed-citation>
              </ref>
              <ref id="R4">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>García-Albéniz</surname><given-names>X</given-names></string-name><string-name><surname>Hsu</surname><given-names>J</given-names></string-name><string-name><surname>Hernán</surname><given-names>MA</given-names></string-name></person-group>. <article-title>The value of explicitly emulating a target trial
when using real world evidence: an application to colorectal cancer
screening</article-title>. <source>Eur J Epidemiol</source>.
<year>2017</year><month>Jun</month>;<volume>32</volume>(<issue>6</issue>):<fpage>495</fpage>–<lpage>500</lpage>.
<pub-id pub-id-type="doi">10.1007/s10654-017-0287-2</pub-id><issn>1573-7284</issn><?supplied-pmid 28748498?><pub-id pub-id-type="pmid">28748498</pub-id></mixed-citation>
              </ref>
              <ref id="R5">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mei</surname><given-names>H</given-names></string-name><string-name><surname>Wang</surname><given-names>J</given-names></string-name><string-name><surname>Ma</surname><given-names>S</given-names></string-name></person-group>. <article-title>An emulated target trial analysis based on
Medicare data suggested non-inferiority of Dabigatran versus
Rivaroxaban</article-title>. <source>J Clin Epidemiol</source>.
<year>2021</year><month>Nov</month>;<volume>139</volume>:<fpage>28</fpage>–<lpage>37</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jclinepi.2021.07.001</pub-id><issn>1878-5921</issn><?supplied-pmid 34271110?><pub-id pub-id-type="pmid">34271110</pub-id></mixed-citation>
              </ref>
              <ref id="R6">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Danaei</surname><given-names>G</given-names></string-name><string-name><surname>García Rodríguez</surname><given-names>LA</given-names></string-name><string-name><surname>Cantero</surname><given-names>OF</given-names></string-name><string-name><surname>Logan</surname><given-names>RW</given-names></string-name><string-name><surname>Hernán</surname><given-names>MA</given-names></string-name></person-group>. <article-title>Electronic medical records can be used to
emulate target trials of sustained treatment strategies</article-title>.
<source>J Clin Epidemiol</source>. <year>2018</year><month>Apr</month>;<volume>96</volume>:<fpage>12</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jclinepi.2017.11.021</pub-id><issn>1878-5921</issn><?supplied-pmid 29203418?><pub-id pub-id-type="pmid">29203418</pub-id></mixed-citation>
              </ref>
              <ref id="R7">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Atkinson</surname><given-names>A</given-names></string-name><string-name><surname>Zwahlen</surname><given-names>M</given-names></string-name><string-name><surname>Barger</surname><given-names>D</given-names></string-name><string-name><surname>d’Arminio Monforte</surname><given-names>A</given-names></string-name><string-name><surname>De Wit</surname><given-names>S</given-names></string-name><string-name><surname>Ghosn</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group><article-title>Withholding primary PcP prophylaxis in virologically suppressed
HIV patients: an emulation of a pragmatic trial in COHERE</article-title>.
<source>Clin Infect Dis</source>. <year>2020</year>&gt;:
<pub-id pub-id-type="doi">10.1093/cid/ciaa615</pub-id><issn>1058-4838</issn><?supplied-pmid 32448894?><pub-id pub-id-type="pmid">32448894</pub-id></mixed-citation>
              </ref>
              <ref id="R8">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Young</surname><given-names>J</given-names></string-name><string-name><surname>Scherrer</surname><given-names>AU</given-names></string-name><string-name><surname>Calmy</surname><given-names>A</given-names></string-name><string-name><surname>Tarr</surname><given-names>PE</given-names></string-name><string-name><surname>Bernasconi</surname><given-names>E</given-names></string-name><string-name><surname>Cavassini</surname><given-names>M</given-names></string-name><etal>et al.</etal><collab>Swiss HIV Cohort Study.</collab></person-group><article-title>The comparative effectiveness of NRTI-sparing dual regimens in
emulated trials using observational data from the Swiss HIV Cohort
Study</article-title>. <source>Antivir Ther</source>.
<year>2019</year>;<volume>24</volume>(<issue>5</issue>):<fpage>343</fpage>–<lpage>53</lpage>.
<pub-id pub-id-type="doi">10.3851/imp3310</pub-id>
<pub-id pub-id-type="doi">10.3851/IMP3310</pub-id><issn>2040-2058</issn><?supplied-pmid 30985290?><pub-id pub-id-type="pmid">30985290</pub-id></mixed-citation>
              </ref>
              <ref id="R9">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Caniglia</surname><given-names>EC</given-names></string-name><string-name><surname>Robins</surname><given-names>JM</given-names></string-name><string-name><surname>Cain</surname><given-names>LE</given-names></string-name><string-name><surname>Sabin</surname><given-names>C</given-names></string-name><string-name><surname>Logan</surname><given-names>R</given-names></string-name><string-name><surname>Abgrall</surname><given-names>S</given-names></string-name><etal>et al.</etal></person-group><article-title>Emulating a trial of joint dynamic strategies: an application to
monitoring and treatment of HIV-positive individuals</article-title>.
<source>Stat Med</source>. <year>2019</year><month>Jun</month>;<volume>38</volume>(<issue>13</issue>):<fpage>2428</fpage>–<lpage>46</lpage>.
<pub-id pub-id-type="doi">10.1002/sim.8120</pub-id><issn>1097-0258</issn><?supplied-pmid 30883859?><pub-id pub-id-type="pmid">30883859</pub-id></mixed-citation>
              </ref>
              <ref id="R10">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lyu</surname><given-names>B</given-names></string-name><string-name><surname>Chan</surname><given-names>MR</given-names></string-name><string-name><surname>Yevzlin</surname><given-names>AS</given-names></string-name><string-name><surname>Gardezi</surname><given-names>A</given-names></string-name><string-name><surname>Astor</surname><given-names>BC</given-names></string-name></person-group>. <article-title>Arteriovenous Access Type and Risk of Mortality,
Hospitalization, and Sepsis Among Elderly Hemodialysis Patients: A Target
Trial Emulation Approach</article-title>. <source>Am J Kidney Dis</source>.
<year>2021</year>: <pub-id pub-id-type="doi">10.1053/j.ajkd.2021.03.030</pub-id><issn>0272-6386</issn><?supplied-pmid 34118301?><pub-id pub-id-type="pmid">34118301</pub-id></mixed-citation>
              </ref>
              <ref id="R11">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffman</surname><given-names>KL</given-names></string-name><string-name><surname>Schenck</surname><given-names>EJ</given-names></string-name><string-name><surname>Satlin</surname><given-names>MJ</given-names></string-name><string-name><surname>Whalen</surname><given-names>W</given-names></string-name><string-name><surname>Pan</surname><given-names>D</given-names></string-name><string-name><surname>Williams</surname><given-names>N</given-names></string-name><etal>et al.</etal></person-group><article-title>Comparison of a target trial emulation framework vs Cox
regression to estimate the association of corticosteroids with COVID-19
mortality</article-title>. <source>JAMA Network Open</source>.
<year>2022</year>;5(10):e2234425-e.</mixed-citation>
              </ref>
              <ref id="R12">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>D’Agostino</surname><given-names>RB</given-names><suffix>Jr</suffix></string-name></person-group>. <article-title>Propensity score methods for bias reduction in
the comparison of a treatment to a non-randomized control
group</article-title>. <source>Stat Med</source>. <year>1998</year><month>Oct</month>;<volume>17</volume>(<issue>19</issue>):<fpage>2265</fpage>–<lpage>81</lpage>.
<pub-id pub-id-type="doi">10.1002/(SICI)1097-0258(19981015)17:19&lt;2265::AID-SIM918&gt;3.0.CO;2-B</pub-id><issn>0277-6715</issn><?supplied-pmid 9802183?><pub-id pub-id-type="pmid">9802183</pub-id></mixed-citation>
              </ref>
              <ref id="R13">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deng</surname><given-names>L</given-names></string-name><string-name><surname>Yu</surname><given-names>D.</given-names></string-name></person-group><article-title>Deep learning: methods and applications.</article-title><source>Foundations and trends® in signal processing</source>. <year>2014</year>;<volume>7</volume>(<issue>3–4</issue>):<fpage>197</fpage>-387.
<pub-id pub-id-type="doi">10.1561/9781601988157</pub-id></mixed-citation>
              </ref>
              <ref id="R14">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>D</given-names></string-name><string-name><surname>Deng</surname><given-names>L</given-names></string-name></person-group>. <article-title>Deep learning and its applications to signal and
information processing</article-title><comment>[exploratory dsp]</comment>. <source>IEEE Signal Process Mag</source>.
<year>2010</year>;<volume>28</volume>(<issue>1</issue>):<fpage>145</fpage>–<lpage>54</lpage>.
<pub-id pub-id-type="doi">10.1109/MSP.2010.939038</pub-id><issn>1053-5888</issn></mixed-citation>
              </ref>
              <ref id="R15">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heaton</surname><given-names>JB</given-names></string-name><string-name><surname>Polson</surname><given-names>NG</given-names></string-name><string-name><surname>Witte</surname><given-names>JH</given-names></string-name></person-group>. <article-title>Deep learning for finance: deep
portfolios</article-title>. <source>Appl Stochastic Models Bus Ind</source>.
<year>2017</year>;<volume>33</volume>(<issue>1</issue>):<fpage>3</fpage>–<lpage>12</lpage>.
<pub-id pub-id-type="doi">10.1002/asmb.2209</pub-id><issn>1524-1904</issn></mixed-citation>
              </ref>
              <ref id="R16">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weichenthal</surname><given-names>S</given-names></string-name><string-name><surname>Hatzopoulou</surname><given-names>M</given-names></string-name><string-name><surname>Brauer</surname><given-names>M</given-names></string-name></person-group>. <article-title>A picture tells a thousand…exposures:
opportunities and challenges of deep learning image analyses in exposure
science and environmental epidemiology</article-title>. <source>Environ
Int</source>. <year>2019</year><month>Jan</month>;<volume>122</volume>:<fpage>3</fpage>–<lpage>10</lpage>.
<pub-id pub-id-type="doi">10.1016/j.envint.2018.11.042</pub-id><issn>1873-6750</issn><?supplied-pmid 30473381?><pub-id pub-id-type="pmid">30473381</pub-id></mixed-citation>
              </ref>
              <ref id="R17">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chaudhary</surname><given-names>K</given-names></string-name><string-name><surname>Poirion</surname><given-names>OB</given-names></string-name><string-name><surname>Lu</surname><given-names>L</given-names></string-name><string-name><surname>Garmire</surname><given-names>LX</given-names></string-name></person-group>. <article-title>Deep learning–based multi-omics integration
robustly predicts survival in liver CancerUsing deep learning to predict
liver cancer prognosis</article-title>. <source>Clin Cancer Res</source>.
<year>2018</year><month>Mar</month>;<volume>24</volume>(<issue>6</issue>):<fpage>1248</fpage>–<lpage>59</lpage>.
<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-17-0853</pub-id><issn>1557-3265</issn><?supplied-pmid 28982688?><pub-id pub-id-type="pmid">28982688</pub-id></mixed-citation>
              </ref>
              <ref id="R18">
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>K</given-names></string-name><string-name><surname>Greenspan</surname><given-names>H</given-names></string-name><string-name><surname>Shen</surname><given-names>D</given-names></string-name></person-group>. <source>Deep learning for medical image analysis</source>.
<publisher-name>Academic Press</publisher-name>;
<year>2017</year>.</mixed-citation>
              </ref>
              <ref id="R19">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ker</surname><given-names>J</given-names></string-name><string-name><surname>Wang</surname><given-names>L</given-names></string-name><string-name><surname>Rao</surname><given-names>J</given-names></string-name><string-name><surname>Lim</surname><given-names>T</given-names></string-name></person-group>. <article-title>Deep learning applications in medical image
analysis</article-title>. <source>IEEE Access</source>.
<year>2017</year>;<volume>6</volume>:<fpage>9375</fpage>–<lpage>89</lpage>.
<pub-id pub-id-type="doi">10.1109/ACCESS.2017.2788044</pub-id><issn>2169-3536</issn></mixed-citation>
              </ref>
              <ref id="R20">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mei</surname><given-names>H</given-names></string-name><string-name><surname>Xu</surname><given-names>Y</given-names></string-name><string-name><surname>Wang</surname><given-names>J</given-names></string-name><string-name><surname>Ma</surname><given-names>S</given-names></string-name></person-group>. <article-title>Evaluation of Survival Outcomes of Endovascular
Versus Open Aortic Repair for Abdominal Aortic Aneurysms with a Big Data
Approach</article-title>. <source>Entropy (Basel)</source>.
<year>2020</year><month>Nov</month>;<volume>22</volume>(<issue>12</issue>):<fpage>1349</fpage>.
<pub-id pub-id-type="doi">10.3390/e22121349</pub-id><issn>1099-4300</issn><?supplied-pmid 33265931?><pub-id pub-id-type="pmid">33265931</pub-id></mixed-citation>
              </ref>
              <ref id="R21">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Falk</surname><given-names>T</given-names></string-name><string-name><surname>Mai</surname><given-names>D</given-names></string-name><string-name><surname>Bensch</surname><given-names>R</given-names></string-name><string-name><surname>Çiçek</surname><given-names>Ö</given-names></string-name><string-name><surname>Abdulkadir</surname><given-names>A</given-names></string-name><string-name><surname>Marrakchi</surname><given-names>Y</given-names></string-name><etal>et al.</etal></person-group><article-title>U-Net: deep learning for cell counting, detection, and
morphometry</article-title>. <source>Nat Methods</source>. <year>2019</year><month>Jan</month>;<volume>16</volume>(<issue>1</issue>):<fpage>67</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1038/s41592-018-0261-2</pub-id><issn>1548-7105</issn><?supplied-pmid 30559429?><pub-id pub-id-type="pmid">30559429</pub-id></mixed-citation>
              </ref>
              <ref id="R22">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sarrazin</surname><given-names>D</given-names></string-name><string-name><surname>Lê</surname><given-names>MG</given-names></string-name><string-name><surname>Arriagada</surname><given-names>R</given-names></string-name><string-name><surname>Contesso</surname><given-names>G</given-names></string-name><string-name><surname>Fontaine</surname><given-names>F</given-names></string-name><string-name><surname>Spielmann</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group><article-title>Ten-year results of a randomized trial comparing a conservative
treatment to mastectomy in early breast cancer</article-title>.
<source>Radiother Oncol</source>. <year>1989</year><month>Mar</month>;<volume>14</volume>(<issue>3</issue>):<fpage>177</fpage>–<lpage>84</lpage>.
<pub-id pub-id-type="doi">10.1016/0167-8140(89)90165-5</pub-id><issn>0167-8140</issn><?supplied-pmid 2652199?><pub-id pub-id-type="pmid">2652199</pub-id></mixed-citation>
              </ref>
              <ref id="R23">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Veronesi</surname><given-names>U</given-names></string-name><string-name><surname>Saccozzi</surname><given-names>R</given-names></string-name><string-name><surname>Del Vecchio</surname><given-names>M</given-names></string-name><string-name><surname>Banfi</surname><given-names>A</given-names></string-name><string-name><surname>Clemente</surname><given-names>C</given-names></string-name><string-name><surname>De Lena</surname><given-names>M</given-names></string-name><etal>et al.</etal></person-group><article-title>Comparing radical mastectomy with quadrantectomy, axillary
dissection, and radiotherapy in patients with small cancers of the
breast</article-title>. <source>N Engl J Med</source>. <year>1981</year><month>Jul</month>;<volume>305</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJM198107023050102</pub-id><issn>0028-4793</issn><?supplied-pmid 7015141?><pub-id pub-id-type="pmid">7015141</pub-id></mixed-citation>
              </ref>
              <ref id="R24">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lichter</surname><given-names>AS</given-names></string-name><string-name><surname>Lippman</surname><given-names>ME</given-names></string-name><string-name><surname>Danforth</surname><given-names>DN</given-names><suffix>Jr</suffix></string-name><string-name><surname>d’Angelo</surname><given-names>T</given-names></string-name><string-name><surname>Steinberg</surname><given-names>SM</given-names></string-name><string-name><surname>deMoss</surname><given-names>E</given-names></string-name><etal>et al.</etal></person-group><article-title>Mastectomy versus breast-conserving therapy in the treatment of
stage I and II carcinoma of the breast: a randomized trial at the National
Cancer Institute</article-title>. <source>J Clin Oncol</source>.
<year>1992</year><month>Jun</month>;<volume>10</volume>(<issue>6</issue>):<fpage>976</fpage>–<lpage>83</lpage>.
<pub-id pub-id-type="doi">10.1200/JCO.1992.10.6.976</pub-id><issn>0732-183X</issn><?supplied-pmid 1588378?><pub-id pub-id-type="pmid">1588378</pub-id></mixed-citation>
              </ref>
              <ref id="R25">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fisher</surname><given-names>B</given-names></string-name><string-name><surname>Anderson</surname><given-names>S</given-names></string-name><string-name><surname>Bryant</surname><given-names>J</given-names></string-name><string-name><surname>Margolese</surname><given-names>RG</given-names></string-name><string-name><surname>Deutsch</surname><given-names>M</given-names></string-name><string-name><surname>Fisher</surname><given-names>ER</given-names></string-name><etal>et al.</etal></person-group><article-title>Twenty-year follow-up of a randomized trial comparing total
mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of
invasive breast cancer</article-title>. <source>N Engl J Med</source>.
<year>2002</year><month>Oct</month>;<volume>347</volume>(<issue>16</issue>):<fpage>1233</fpage>–<lpage>41</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa022152</pub-id><issn>1533-4406</issn><?supplied-pmid 12393820?><pub-id pub-id-type="pmid">12393820</pub-id></mixed-citation>
              </ref>
              <ref id="R26">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>BD</given-names></string-name><string-name><surname>Jiang</surname><given-names>J</given-names></string-name><string-name><surname>McLaughlin</surname><given-names>SS</given-names></string-name><string-name><surname>Hurria</surname><given-names>A</given-names></string-name><string-name><surname>Smith</surname><given-names>GL</given-names></string-name><string-name><surname>Giordano</surname><given-names>SH</given-names></string-name><etal>et al.</etal></person-group><article-title>Improvement in breast cancer outcomes over time: are older women
missing out?</article-title><source>J Clin Oncol</source>. <year>2011</year><month>Dec</month>;<volume>29</volume>(<issue>35</issue>):<fpage>4647</fpage>–<lpage>53</lpage>.
<pub-id pub-id-type="doi">10.1200/JCO.2011.35.8408</pub-id><issn>1527-7755</issn><?supplied-pmid 22067407?><pub-id pub-id-type="pmid">22067407</pub-id></mixed-citation>
              </ref>
              <ref id="R27">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schonberg</surname><given-names>MA</given-names></string-name><string-name><surname>Marcantonio</surname><given-names>ER</given-names></string-name><string-name><surname>Li</surname><given-names>D</given-names></string-name><string-name><surname>Silliman</surname><given-names>RA</given-names></string-name><string-name><surname>Ngo</surname><given-names>L</given-names></string-name><string-name><surname>McCarthy</surname><given-names>EP</given-names></string-name></person-group>. <article-title>Breast cancer among the oldest old: tumor
characteristics, treatment choices, and survival</article-title>. <source>J
Clin Oncol</source>. <year>2010</year><month>Apr</month>;<volume>28</volume>(<issue>12</issue>):<fpage>2038</fpage>–<lpage>45</lpage>.
<pub-id pub-id-type="doi">10.1200/JCO.2009.25.9796</pub-id><issn>1527-7755</issn><?supplied-pmid 20308658?><pub-id pub-id-type="pmid">20308658</pub-id></mixed-citation>
              </ref>
              <ref id="R28">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Emilsson</surname><given-names>L</given-names></string-name><string-name><surname>García-Albéniz</surname><given-names>X</given-names></string-name><string-name><surname>Logan</surname><given-names>RW</given-names></string-name><string-name><surname>Caniglia</surname><given-names>EC</given-names></string-name><string-name><surname>Kalager</surname><given-names>M</given-names></string-name><string-name><surname>Hernán</surname><given-names>MA</given-names></string-name></person-group>. <article-title>Examining bias in studies of statin treatment
and survival in patients with cancer</article-title>. <source>JAMA
Oncol</source>. <year>2018</year><month>Jan</month>;<volume>4</volume>(<issue>1</issue>):<fpage>63</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1001/jamaoncol.2017.2752</pub-id><issn>2374-2445</issn><?supplied-pmid 28822996?><pub-id pub-id-type="pmid">28822996</pub-id></mixed-citation>
              </ref>
              <ref id="R29">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Agarwal</surname><given-names>S</given-names></string-name><string-name><surname>Pappas</surname><given-names>L</given-names></string-name><string-name><surname>Neumayer</surname><given-names>L</given-names></string-name><string-name><surname>Kokeny</surname><given-names>K</given-names></string-name><string-name><surname>Agarwal</surname><given-names>J</given-names></string-name></person-group>. <article-title>Effect of breast conservation therapy vs
mastectomy on disease-specific survival for early-stage breast
cancer</article-title>. <source>JAMA Surg</source>. <year>2014</year><month>Mar</month>;<volume>149</volume>(<issue>3</issue>):<fpage>267</fpage>–<lpage>74</lpage>.
<pub-id pub-id-type="doi">10.1001/jamasurg.2013.3049</pub-id><issn>2168-6262</issn><?supplied-pmid 24429935?><pub-id pub-id-type="pmid">24429935</pub-id></mixed-citation>
              </ref>
              <ref id="R30">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hwang</surname><given-names>ES</given-names></string-name><string-name><surname>Lichtensztajn</surname><given-names>DY</given-names></string-name><string-name><surname>Gomez</surname><given-names>SL</given-names></string-name><string-name><surname>Fowble</surname><given-names>B</given-names></string-name><string-name><surname>Clarke</surname><given-names>CA</given-names></string-name></person-group>. <article-title>Survival after lumpectomy and mastectomy for
early stage invasive breast cancer: the effect of age and hormone receptor
status</article-title>. <source>Cancer</source>. <year>2013</year><month>Apr</month>;<volume>119</volume>(<issue>7</issue>):<fpage>1402</fpage>–<lpage>11</lpage>.
<pub-id pub-id-type="doi">10.1002/cncr.27795</pub-id><issn>1097-0142</issn><?supplied-pmid 23359049?><pub-id pub-id-type="pmid">23359049</pub-id></mixed-citation>
              </ref>
              <ref id="R31">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mogal</surname><given-names>HD</given-names></string-name><string-name><surname>Clark</surname><given-names>C</given-names></string-name><string-name><surname>Dodson</surname><given-names>R</given-names></string-name><string-name><surname>Fino</surname><given-names>NF</given-names></string-name><string-name><surname>Howard-McNatt</surname><given-names>M</given-names></string-name></person-group>. <article-title>Outcomes after mastectomy and lumpectomy in
elderly patients with early-stage breast cancer</article-title>. <source>Ann
Surg Oncol</source>. <year>2017</year><month>Jan</month>;<volume>24</volume>(<issue>1</issue>):<fpage>100</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1245/s10434-016-5582-8</pub-id><issn>1534-4681</issn><?supplied-pmid 27654110?><pub-id pub-id-type="pmid">27654110</pub-id></mixed-citation>
              </ref>
              <ref id="R32">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wrubel</surname><given-names>E</given-names></string-name><string-name><surname>Natwick</surname><given-names>R</given-names></string-name><string-name><surname>Wright</surname><given-names>GP</given-names></string-name></person-group>. <article-title>Breast-conserving therapy is associated with
improved survival compared with mastectomy for early-stage breast cancer: a
propensity score matched comparison using the national cancer
database</article-title>. <source>Ann Surg Oncol</source>. <year>2021</year><month>Feb</month>;<volume>28</volume>(<issue>2</issue>):<fpage>914</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1245/s10434-020-08829-4</pub-id><issn>1534-4681</issn><?supplied-pmid 32661849?><pub-id pub-id-type="pmid">32661849</pub-id></mixed-citation>
              </ref>
              <ref id="R33">
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Hernán</surname><given-names>MA</given-names></string-name><string-name><surname>Robins</surname><given-names>JM</given-names></string-name></person-group>. <source>Causal Inference: What If</source>. <publisher-loc>Boca
Raton</publisher-loc>: <publisher-name>Chapman &amp;
Hall/CRC</publisher-name>; <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="R34">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Danaei</surname><given-names>G</given-names></string-name><string-name><surname>Rodríguez</surname><given-names>LA</given-names></string-name><string-name><surname>Cantero</surname><given-names>OF</given-names></string-name><string-name><surname>Logan</surname><given-names>R</given-names></string-name><string-name><surname>Hernán</surname><given-names>MA</given-names></string-name></person-group>. <article-title>Observational data for comparative effectiveness
research: an emulation of randomised trials of statins and primary
prevention of coronary heart disease</article-title>. <source>Stat Methods
Med Res</source>. <year>2013</year><month>Feb</month>;<volume>22</volume>(<issue>1</issue>):<fpage>70</fpage>–<lpage>96</lpage>.
<pub-id pub-id-type="doi">10.1177/0962280211403603</pub-id><issn>1477-0334</issn><?supplied-pmid 22016461?><pub-id pub-id-type="pmid">22016461</pub-id></mixed-citation>
              </ref>
              <ref id="R35">
                <mixed-citation publication-type="webpage"><person-group person-group-type="author"><string-name><surname>Stuart</surname><given-names>E</given-names></string-name></person-group>. <article-title>Propensity Score Software</article-title>
[<date-in-citation content-type="access-date">cited 2023 May
23</date-in-citation>]. Available from: <ext-link xlink:href="https://www.elizabethstuart.org/psoftware/" ext-link-type="uri">https://www.elizabethstuart.org/psoftware/</ext-link></mixed-citation>
              </ref>
              <ref id="R36">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meier</surname><given-names>L</given-names></string-name><string-name><surname>Van De Geer</surname><given-names>S</given-names></string-name><string-name><surname>Bühlmann</surname><given-names>P</given-names></string-name></person-group>. <article-title>The group lasso for logistic
regression</article-title>. <source>J R Stat Soc Series B Stat
Methodol</source>.
<year>2008</year>;<volume>70</volume>(<issue>1</issue>):<fpage>53</fpage>–<lpage>71</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1467-9868.2007.00627.x</pub-id><issn>1369-7412</issn></mixed-citation>
              </ref>
              <ref id="R37">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hastie</surname><given-names>T</given-names></string-name></person-group>. <article-title>Ridge regularization: an essential concept in
data science</article-title>. <source>Technometrics</source>.
<year>2020</year>;<volume>62</volume>(<issue>4</issue>):<fpage>426</fpage>–<lpage>33</lpage>.
<pub-id pub-id-type="doi">10.1080/00401706.2020.1791959</pub-id><issn>0040-1706</issn><?supplied-pmid 36033922?><pub-id pub-id-type="pmid">36033922</pub-id></mixed-citation>
              </ref>
              <ref id="R38">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Katzman</surname><given-names>JL</given-names></string-name><string-name><surname>Shaham</surname><given-names>U</given-names></string-name><string-name><surname>Cloninger</surname><given-names>A</given-names></string-name><string-name><surname>Bates</surname><given-names>J</given-names></string-name><string-name><surname>Jiang</surname><given-names>T</given-names></string-name><string-name><surname>Kluger</surname><given-names>Y</given-names></string-name></person-group>. <article-title>DeepSurv: personalized treatment recommender
system using a Cox proportional hazards deep neural network</article-title>.
<source>BMC Med Res Methodol</source>. <year>2018</year><month>Feb</month>;<volume>18</volume>(<issue>1</issue>):<fpage>24</fpage>.
<pub-id pub-id-type="doi">10.1186/s12874-018-0482-1</pub-id><issn>1471-2288</issn><?supplied-pmid 29482517?><pub-id pub-id-type="pmid">29482517</pub-id></mixed-citation>
              </ref>
              <ref id="R39">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wei</surname><given-names>LJ</given-names></string-name></person-group>. <article-title>The accelerated failure time model: a useful
alternative to the Cox regression model in survival
analysis</article-title>. <source>Stat Med</source>.
<year>1992</year>;<volume>11</volume>(<issue>14-15</issue>):<fpage>1871</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1002/sim.4780111409</pub-id><issn>0277-6715</issn><?supplied-pmid 1480879?><pub-id pub-id-type="pmid">1480879</pub-id></mixed-citation>
              </ref>
              <ref id="R40">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stute</surname><given-names>W</given-names></string-name></person-group>. <article-title>Nonlinear censored regression</article-title>.
<source>Stat Sin</source>.
<year>1999</year>:<fpage>1089</fpage>–<lpage>102</lpage>.<issn>1017-0405</issn></mixed-citation>
              </ref>
              <ref id="R41">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stute</surname><given-names>W</given-names></string-name></person-group>. <article-title>Consistent estimation under random censorship
when covariables are present</article-title>. <source>J Multivariate
Anal</source>.
<year>1993</year>;<volume>45</volume>(<issue>1</issue>):<fpage>89</fpage>–<lpage>103</lpage>.
<pub-id pub-id-type="doi">10.1006/jmva.1993.1028</pub-id><issn>0047-259X</issn></mixed-citation>
              </ref>
              <ref id="R42">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>S</given-names></string-name><string-name><surname>Kosorok</surname><given-names>MR</given-names></string-name></person-group>. <article-title>Robust semiparametric M-estimation and the
weighted bootstrap</article-title>. <source>J Multivariate Anal</source>.
<year>2005</year>;<volume>96</volume>(<issue>1</issue>):<fpage>190</fpage>–<lpage>217</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jmva.2004.09.008</pub-id><issn>0047-259X</issn></mixed-citation>
              </ref>
              <ref id="R43">
                <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Hastie</surname><given-names>T</given-names></string-name><string-name><surname>Tibshirani</surname><given-names>R</given-names></string-name><string-name><surname>Friedman</surname><given-names>JH</given-names></string-name><string-name><surname>Friedman</surname><given-names>JH</given-names></string-name></person-group>. <source>The elements of statistical learning: data mining,
inference, and prediction</source>.
<publisher-name>Springer</publisher-name>; <year>2009</year>. <pub-id pub-id-type="doi">10.1007/978-0-387-84858-7</pub-id></mixed-citation>
              </ref>
              <ref id="R44">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fiks</surname><given-names>AG</given-names></string-name><string-name><surname>Grundmeier</surname><given-names>RW</given-names></string-name><string-name><surname>Margolis</surname><given-names>B</given-names></string-name><string-name><surname>Bell</surname><given-names>LM</given-names></string-name><string-name><surname>Steffes</surname><given-names>J</given-names></string-name><string-name><surname>Massey</surname><given-names>J</given-names></string-name><etal>et al.</etal></person-group><article-title>Comparative effectiveness research using the electronic medical
record: an emerging area of investigation in pediatric primary
care</article-title>. <source>J Pediatr</source>. <year>2012</year><month>May</month>;<volume>160</volume>(<issue>5</issue>):<fpage>719</fpage>–<lpage>24</lpage>.
<pub-id pub-id-type="doi">10.1016/j.jpeds.2012.01.039</pub-id><issn>1097-6833</issn><?supplied-pmid 22364853?><pub-id pub-id-type="pmid">22364853</pub-id></mixed-citation>
              </ref>
              <ref id="R45">
                <mixed-citation publication-type="confproc"><person-group person-group-type="editor"><string-name><surname>Pearce</surname><given-names>T</given-names></string-name><string-name><surname>Brintrup</surname><given-names>A</given-names></string-name><string-name><surname>Zaki</surname><given-names>M</given-names></string-name><string-name><surname>Neely</surname><given-names>A</given-names></string-name></person-group>. <article-title>High-quality prediction
intervals for deep learning: A distribution-free, ensembled
approach.</article-title><source>International conference on machine learning</source>;
<year>2018</year>: PMLR.</mixed-citation>
              </ref>
              <ref id="R46">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lakshminarayanan</surname><given-names>B</given-names></string-name><string-name><surname>Pritzel</surname><given-names>A</given-names></string-name><string-name><surname>Blundell</surname><given-names>C</given-names></string-name></person-group>. <article-title>Simple and scalable predictive uncertainty
estimation using deep ensembles</article-title>. <source>Adv Neural Inf
Process Syst</source>.
<year>2017</year>:<fpage>30</fpage>.<issn>1049-5258</issn></mixed-citation>
              </ref>
              <ref id="R47">
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Veronesi</surname><given-names>U</given-names></string-name><string-name><surname>Cascinelli</surname><given-names>N</given-names></string-name><string-name><surname>Mariani</surname><given-names>L</given-names></string-name><string-name><surname>Greco</surname><given-names>M</given-names></string-name><string-name><surname>Saccozzi</surname><given-names>R</given-names></string-name><string-name><surname>Luini</surname><given-names>A</given-names></string-name><etal>et al.</etal></person-group><article-title>Twenty-year follow-up of a randomized study comparing
breast-conserving surgery with radical mastectomy for early breast
cancer</article-title>. <source>N Engl J Med</source>. <year>2002</year><month>Oct</month>;<volume>347</volume>(<issue>16</issue>):<fpage>1227</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa020989</pub-id><issn>1533-4406</issn><?supplied-pmid 12393819?><pub-id pub-id-type="pmid">12393819</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="F1">
              <label>Figure 1</label>
              <caption>
                <p><bold>Flowchart of sample selection</bold>.</p>
              </caption>
              <graphic xlink:href="yjbm_96_3_327_g01" position="float"/>
            </fig>
            <fig position="float" id="F2">
              <label>Figure 2</label>
              <caption>
                <p><bold>Scheme of the proposed DNN-based analysis</bold>.</p>
              </caption>
              <graphic xlink:href="yjbm_96_3_327_g02" position="float"/>
            </fig>
            <fig position="float" id="F3">
              <label>Figure 3</label>
              <caption>
                <p><bold>Unadjusted survival analysis</bold>.</p>
              </caption>
              <graphic xlink:href="yjbm_96_3_327_g03" position="float"/>
            </fig>
            <fig position="float" id="F4">
              <label>Figure 4</label>
              <caption>
                <p><bold>Parameter paths for the propensity score analysis (upper) and survival
analysis (lower)</bold>.</p>
              </caption>
              <graphic xlink:href="yjbm_96_3_327_g04" position="float"/>
            </fig>
            <fig position="float" id="F5">
              <label>Figure 5</label>
              <caption>
                <p><bold>Distributions of estimated (a) propensity score and (b) inverse probability
treatment weights; and (c) absolute standard mean difference of all
confounders before and after weighting</bold>.</p>
              </caption>
              <graphic xlink:href="yjbm_96_3_327_g05" position="float"/>
            </fig>
            <fig position="float" id="F6">
              <label>Figure 6</label>
              <caption>
                <p><bold>Analysis of predicted survival: (a) predicted subject-level improvement in
survival if a patient would switch treatment; (b) survival probabilities
based on the predicted survival times if the treatment assignment was
random; and (c) survival probabilities with patients under the original
observed treatments</bold>.</p>
              </caption>
              <graphic xlink:href="yjbm_96_3_327_g06" position="float"/>
            </fig>
            <table-wrap position="float" id="T1">
              <label>Table 1</label>
              <caption>
                <title>Patients’ Characteristics by Treatment</title>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1">
                      <bold>Mastectomy (n = 15,293)</bold>
                    </td>
                    <td rowspan="1" colspan="1">
                      <bold>Lumpectomy (n = 50,704)</bold>
                    </td>
                    <td rowspan="1" colspan="1">
                      <bold>Overall (n = 65,997)</bold>
                    </td>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td rowspan="1" colspan="1">
                      <bold>Demographics</bold>
                    </td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Age at diagnosis</bold></td>
                    <td rowspan="1" colspan="1">76.1 (6.85)</td>
                    <td rowspan="1" colspan="1">75.3 (6.55)</td>
                    <td rowspan="1" colspan="1">75.5 (6.63)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Race (Non-Hispanic White)</bold></td>
                    <td rowspan="1" colspan="1">12474 (81.6%)</td>
                    <td rowspan="1" colspan="1">43038 (84.9%)</td>
                    <td rowspan="1" colspan="1">55512 (84.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Marital Status (married)</bold></td>
                    <td rowspan="1" colspan="1">6715 (43.9%)</td>
                    <td rowspan="1" colspan="1">25048 (49.4%)</td>
                    <td rowspan="1" colspan="1">31763 (48.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Year of diagnosis</bold></td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2007</bold></td>
                    <td rowspan="1" colspan="1">1571 (10.3%)</td>
                    <td rowspan="1" colspan="1">4586 (9.0%)</td>
                    <td rowspan="1" colspan="1">6157 (9.3%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2008</bold></td>
                    <td rowspan="1" colspan="1">1540 (10.1%)</td>
                    <td rowspan="1" colspan="1">4535 (8.9%)</td>
                    <td rowspan="1" colspan="1">6075 (9.2%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2009</bold></td>
                    <td rowspan="1" colspan="1">1493 (9.8%)</td>
                    <td rowspan="1" colspan="1">4504 (8.9%)</td>
                    <td rowspan="1" colspan="1">5997 (9.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2010</bold></td>
                    <td rowspan="1" colspan="1">1456 (9.5%)</td>
                    <td rowspan="1" colspan="1">4468 (8.8%)</td>
                    <td rowspan="1" colspan="1">5924 (9.0%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2011</bold></td>
                    <td rowspan="1" colspan="1">1472 (9.6%)</td>
                    <td rowspan="1" colspan="1">4575 (9.0%)</td>
                    <td rowspan="1" colspan="1">6047 (9.2%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2012</bold></td>
                    <td rowspan="1" colspan="1">1512 (9.9%)</td>
                    <td rowspan="1" colspan="1">4508 (8.9%)</td>
                    <td rowspan="1" colspan="1">6020 (9.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2013</bold></td>
                    <td rowspan="1" colspan="1">1475 (9.6%)</td>
                    <td rowspan="1" colspan="1">4493 (8.9%)</td>
                    <td rowspan="1" colspan="1">5968 (9.0%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2014</bold></td>
                    <td rowspan="1" colspan="1">1373 (9.0%)</td>
                    <td rowspan="1" colspan="1">4561 (9.0%)</td>
                    <td rowspan="1" colspan="1">5934 (9.0%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2015</bold></td>
                    <td rowspan="1" colspan="1">1244 (8.1%)</td>
                    <td rowspan="1" colspan="1">4721 (9.3%)</td>
                    <td rowspan="1" colspan="1">5965 (9.0%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2016</bold></td>
                    <td rowspan="1" colspan="1">1126 (7.4%)</td>
                    <td rowspan="1" colspan="1">4902 (9.7%)</td>
                    <td rowspan="1" colspan="1">6028 (9.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>2017</bold></td>
                    <td rowspan="1" colspan="1">1031 (6.7%)</td>
                    <td rowspan="1" colspan="1">4851 (9.6%)</td>
                    <td rowspan="1" colspan="1">5882 (8.9%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1">
                      <bold>Tumor characteristics</bold>
                    </td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Morphology</bold></td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Intraductal</bold></td>
                    <td rowspan="1" colspan="1">12194 (79.7%)</td>
                    <td rowspan="1" colspan="1">42100 (83.0%)</td>
                    <td rowspan="1" colspan="1">54294 (82.3%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Lobular</bold></td>
                    <td rowspan="1" colspan="1">2046 (13.4%)</td>
                    <td rowspan="1" colspan="1">5498 (10.8%)</td>
                    <td rowspan="1" colspan="1">7544 (11.4%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Intraductal and Lobular</bold></td>
                    <td rowspan="1" colspan="1">1053 (6.9%)</td>
                    <td rowspan="1" colspan="1">3106 (6.1%)</td>
                    <td rowspan="1" colspan="1">4159 (6.3%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Tumor size (mm)</bold></td>
                    <td rowspan="1" colspan="1">20.6 (11.1)</td>
                    <td rowspan="1" colspan="1">14.6 (8.74)</td>
                    <td rowspan="1" colspan="1">16.0 (9.68)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Stage (II vs ref: I)</bold></td>
                    <td rowspan="1" colspan="1">8235 (53.8%)</td>
                    <td rowspan="1" colspan="1">14236 (28.1%)</td>
                    <td rowspan="1" colspan="1">22471 (34.0%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Primary site</bold></td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Nipple</bold></td>
                    <td rowspan="1" colspan="1">74 (0.5%)</td>
                    <td rowspan="1" colspan="1">186 (0.4%)</td>
                    <td rowspan="1" colspan="1">260 (0.4%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Central</bold></td>
                    <td rowspan="1" colspan="1">1193 (7.8%)</td>
                    <td rowspan="1" colspan="1">2168 (4.3%)</td>
                    <td rowspan="1" colspan="1">3361 (5.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>UIQ</bold></td>
                    <td rowspan="1" colspan="1">1682 (11.0%)</td>
                    <td rowspan="1" colspan="1">6942 (13.7%)</td>
                    <td rowspan="1" colspan="1">8624 (13.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>LIQ</bold></td>
                    <td rowspan="1" colspan="1">878 (5.7%)</td>
                    <td rowspan="1" colspan="1">3203 (6.3%)</td>
                    <td rowspan="1" colspan="1">4081 (6.2%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>UOQ</bold></td>
                    <td rowspan="1" colspan="1">4671 (30.5%)</td>
                    <td rowspan="1" colspan="1">18704 (36.9%)</td>
                    <td rowspan="1" colspan="1">23375 (35.4%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>LOQ</bold></td>
                    <td rowspan="1" colspan="1">1133 (7.4%)</td>
                    <td rowspan="1" colspan="1">3717 (7.3%)</td>
                    <td rowspan="1" colspan="1">4850 (7.3%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Axillary tail</bold></td>
                    <td rowspan="1" colspan="1">38 (0.2%)</td>
                    <td rowspan="1" colspan="1">207 (0.4%)</td>
                    <td rowspan="1" colspan="1">245 (0.4%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Overlapping lesion</bold></td>
                    <td rowspan="1" colspan="1">3417 (22.3%)</td>
                    <td rowspan="1" colspan="1">11850 (23.4%)</td>
                    <td rowspan="1" colspan="1">15267 (23.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Breast, NOS</bold></td>
                    <td rowspan="1" colspan="1">2207 (14.4%)</td>
                    <td rowspan="1" colspan="1">3727 (7.4%)</td>
                    <td rowspan="1" colspan="1">5934 (9.0%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Laterality</bold></td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Right: origin of primary</bold></td>
                    <td rowspan="1" colspan="1">7454 (48.7%)</td>
                    <td rowspan="1" colspan="1">25053 (49.4%)</td>
                    <td rowspan="1" colspan="1">32507 (49.3%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Left: origin of primary</bold></td>
                    <td rowspan="1" colspan="1">&gt;7828 (&gt;51.2%)</td>
                    <td rowspan="1" colspan="1">&gt;25640 (&gt;50.6%)</td>
                    <td rowspan="1" colspan="1">&gt;33479 (&gt;50.7%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Other or unspecified</bold></td>
                    <td rowspan="1" colspan="1">&lt;11</td>
                    <td rowspan="1" colspan="1">&lt;11</td>
                    <td rowspan="1" colspan="1">&lt;11</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Grade</bold></td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>I</bold></td>
                    <td rowspan="1" colspan="1">3266 (21.4%)</td>
                    <td rowspan="1" colspan="1">14862 (29.3%)</td>
                    <td rowspan="1" colspan="1">18128 (27.5%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>II</bold></td>
                    <td rowspan="1" colspan="1">7281 (47.6%)</td>
                    <td rowspan="1" colspan="1">24097 (47.5%)</td>
                    <td rowspan="1" colspan="1">31378 (47.5%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>III</bold></td>
                    <td rowspan="1" colspan="1">4366 (28.5%)</td>
                    <td rowspan="1" colspan="1">10376 (20.5%)</td>
                    <td rowspan="1" colspan="1">14742 (22.3%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>IV</bold></td>
                    <td rowspan="1" colspan="1">43 (0.3%)</td>
                    <td rowspan="1" colspan="1">103 (0.2%)</td>
                    <td rowspan="1" colspan="1">146 (0.2%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Unknown</bold></td>
                    <td rowspan="1" colspan="1">337 (2.2%)</td>
                    <td rowspan="1" colspan="1">1266 (2.5%)</td>
                    <td rowspan="1" colspan="1">1603 (2.4%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>HR status</bold></td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Positive or borderline</bold></td>
                    <td rowspan="1" colspan="1">12742 (83.3%)</td>
                    <td rowspan="1" colspan="1">44922 (88.6%)</td>
                    <td rowspan="1" colspan="1">57664 (87.4%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Negative</bold></td>
                    <td rowspan="1" colspan="1">2111 (13.8%)</td>
                    <td rowspan="1" colspan="1">4856 (9.6%)</td>
                    <td rowspan="1" colspan="1">6967 (10.6%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Unknown</bold></td>
                    <td rowspan="1" colspan="1">440 (2.9%)</td>
                    <td rowspan="1" colspan="1">926 (1.8%)</td>
                    <td rowspan="1" colspan="1">1366 (2.1%)</td>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1">
                      <bold>Elixhauser Comorbidities</bold>
                    </td>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                    <td rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td rowspan="1" colspan="1"> <bold>Comorbidity index</bold></td>
                    <td rowspan="1" colspan="1">9.62 (8.28)</td>
                    <td rowspan="1" colspan="1">7.47 (6.79)</td>
                    <td rowspan="1" colspan="1">7.97 (7.22)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <p>*For a categorical variable, count (percent). For a continuous variable, mean
(standard deviation).</p>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
